Grace, Peter |
University Of Tx Md Anderson Can Ctr |
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain |
Supportive Care and Symptom Management, Cognitive Dysfunction |
RFA-CA-17-017: Research Answers to NCI's Provocative Questions |
Gray, Robert J |
Dana-Farber Cancer Inst |
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) |
Supportive Care and Symptom Management, Multiple Symptoms, Other Supportive Care Issues |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
Gross, Howard M |
Dayton Clinical Oncology Program |
Dayton Clinical Oncology Program |
NCI Community Oncology Research Program, NCORP Community Sites |
RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites |
Grueber, Wesley B |
Columbia University Health Sciences |
Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy |
Supportive Care and Symptom Management, Pain |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
Halmos, Balazs |
Montefiore Medical Center (Bronx, Ny) |
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM |
NCI Community Oncology Research Program, NCORP Minority Underserved |
RFA-CA-18-017: NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites |
Hanks, Brent Allen |
Duke University |
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities |
Supportive Care and Symptom Management, Multiple Symptoms |
PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
Herrmann, Joerg |
Mayo Clinic Rochester |
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial |
Supportive Care and Symptom Management, Cardiotoxicity |
PA-18-003: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
Hill, Deirdre |
University Of New Mexico Health Scis Ctr |
Chronic Kidney Disease Development in Cancer Treatment and Survival |
Supportive Care and Symptom Management, Urinary Complications |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
Hinds, Pamela S |
Children'S Research Institute |
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment |
Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
PA-16-160: NIH Research Project Grant |
Hoffman, Amy Jude |
University Of Nebraska Medical Center |
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients |
Supportive Care and Symptom Management, Fatigue |
PA-16-160: NIH Research Project Grant |
Hu, Jim |
Weill Medical Coll Of Cornell Univ |
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) |
Supportive Care and Symptom Management, Quality of Life, Sexual Health |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
Hu, Shuiying |
Ohio State University |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
Provocative QuestionsSupportive Care and Symptom Management, Neuropathy |
RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions |
Huberty, Jennifer Lynne |
University Of Texas Hlth Science Center |
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients |
Supportive Care and Symptom Management, Sleep Disorders |
PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
Hui, David |
University Of Tx Md Anderson Can Ctr |
Strategies for Persistent Agitated Delirium in Palliative Care |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
Hui, David |
University Of Tx Md Anderson Can Ctr |
Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients |
Supportive Care and Symptom Management, Other Supportive Care Issues |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |